Heart to Heart: A Chat About Heart Disease Risk in Women
- This event has passed.
February 14, 2024 @ 2:00 pm - 2:30 pm EST
Ischemic heart disease (IHD) refers to the reduced blood flow and oxygen supply to the heart, usually caused by plaque buildup in the arteries surrounding the heart. IHD is also known as coronary artery or coronary heart disease. IHD is a leading cause of death for women in the United States, yet there are significant awareness gaps about the impacts of IHD in women. According to the Centers for Disease Control and Prevention (CDC), IHD is the cause of death for 3.8% of women ages 15-49 years, 9% of women ages 50-64 years, and 12% of women 65+ years.
Studies have identified that women experience different symptoms of IHD – one of the largest differences being that women are less likely to have chest pain, which is commonly experienced in men. The complex relationship between risk factors and symptoms of IHD, and sex-specific health events over the lifespan contribute to the disparities observed in the prevention, treatment, and outcomes of IHD between men and women.
SWHR hosted an Instagram Live event with a cardiology and women’s health expert to discuss the prevention and treatment of IHD in women across the lifespan, with a focus on young women.
Speakers
Nieca Goldberg, MD
Nieca Goldberg, MD
Dr. Nieca Goldberg is Medical Director of Atria New York City and Clinical Associate Professor of medicine at NYU Grossman School of Medicine. She was the Co-Medical Director of the 92nd Street Y’s Cardio Rehab Program. Dr. Goldberg is a cardiologist, author, and podcast host of “Beyond the Heart – Improving Your Health One Conversation at a Time,” and a nationally recognized pioneer in women’s heart health. Dr. Goldberg is a national spokesperson for the American Heart Association and started the “Go Red for Women” campaign. Before joining Atria New York City, she was medical director of NYU Women’s Heart Program, Senior Advisor of Women’s Health Strategy NYU Langone Health, the founder, and Medical Director of the Joan H. Tisch Center for Women’s Health at the NYU Langone Medical Center.
Irene O. Aninye, PhD
Irene O. Aninye, PhD
As the Chief Science Officer of the Society for Women’s Health Research, Dr. Irene O. Aninye steers SWHR’s portfolio of scientific programs to increase awareness and investment in research on biological sex differences and health conditions that disproportionately or uniquely affect women. She convenes expert working groups and meetings to identify strategies that address persistent gaps in women’s health care and research, translating recommendations into science-based and patient-centered policy solutions. Dr. Aninye has led the development of white papers, health care roadmaps, patient toolkits, clinical education materials, and calls to action for women’s cardiovascular health, autoimmune diseases, menopause, Alzheimer’s disease, HPV, and endometriosis, among other areas.
Prior to joining SWHR, Aninye worked at the American Association for the Advancement of Science (AAAS), where she led strategy teams to evaluate the progress and outcomes of multidisciplinary STEM research and training programs for university consortia. She also designed peer-review systems for externally organized competitions and facilitated workshops to build research capacity and competitiveness in the U.S. and abroad.
Aninye completed her PhD in molecular and integrative physiology at the University of Illinois at Urbana-Champaign, where her research focused on identifying and characterizing novel small molecule inhibitors of progesterone receptor action in breast cancer. After completing postdoctoral training at Johns Hopkins University School of Medicine, she continued her research endeavors in endocrinology and metabolism – investigating sex steroid hormones and their receptor-mediated actions in development, reproduction, and disease.
In addition to research, Aninye has dedicated her career to engaging the scientific community through academic service, outreach, and teaching. At the National Institutes of Health (NIH), she developed CEU courses in biotechnology and innovation for clinicians and basic researchers through the Foundation for Advanced Education in the Sciences (FAES@NIH). She was also a member of the biology faculty at Loyola University Maryland.
With a passion to diversify the face of STEM and increase the involvement of underrepresented groups in the sciences, she provides scientific and leadership training across all career stages and serves on advisory boards for the National Institutes of Health, American Cancer Society, National Health Council, and World Economic Forum’s Global Alliance for Women’s Health.
A Washington, DC, native, Dr. Aninye attended the University of Maryland, Baltimore County (UMBC) as a Meyerhoff Scholar and holds a BS in biochemistry and molecular biology.
